pd 98059 has been researched along with Graft-Versus-Host Disease in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, YC | 1 |
| Li, SC | 1 |
| Hsu, CK | 1 |
| Yu, CC | 1 |
| Lin, TJ | 1 |
| Lee, CY | 1 |
| Liao, HF | 1 |
1 trial available for pd 98059 and Graft-Versus-Host Disease
| Article | Year |
|---|---|
G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT.
Topics: Adult; Androstadienes; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoi | 2012 |